Assessing physician practices and expectations in the post-COVID eraThe ongoing COVID-19 pandemic has affected the routines of many practicing physicians, including an impact on their prescribing Share XAssessing physician practices and expectations in the post-COVID erahttps://pharmaphorum.com/views-analysis-patients/assessing-physician-practices-and-expectations-in-the-post-covid-era/
3 practical steps for improving patient supportResearch Partnership’s Emilie Braund and Harrison Gaiger dig down into the top insights pharma companies can harness to Share X3 practical steps for improving patient supporthttps://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/practical-steps-for-improving-patient-support/
Plugging modular content into pharma’s omnichannel strategies86% of respondents to a recent Veeva survey of pharma and biotech professionals said they are creating a Share XPlugging modular content into pharma’s omnichannel strategieshttps://pharmaphorum.com/whitepapers/plugging-modular-content-into-pharmas-omnichannel-strategies/
Unlocking the potential in rare disease research with decentralised trialsA survey by rare disease patient network Raremark found that 86% of the community members asked were interested Share XUnlocking the potential in rare disease research with decentralised trialshttps://pharmaphorum.com/views-analysis-patients/unlocking-the-potential-in-rare-disease-research-with-decentralised-trials/
Pharma digital transformation: customer data expected to play a pivotal roleA new survey highlights the importance of customer reference data to digital transformation and analyses ways pharma companies Share XPharma digital transformation: customer data expected to play a pivotal rolehttps://pharmaphorum.com/whitepapers/pharma-digital-transformation-customer-data-expected-to-play-a-pivotal-role/
The elective care conundrum – can digital innovation help?Karina Malhotra from Acumentice explores how digital tech and data could help address the NHS elective care backlog Share XThe elective care conundrum – can digital innovation help?https://pharmaphorum.com/digital/the-elective-care-conundrum/
A collaborative approach to greater diversity in clinical trialsThe need for diversity in clinical trial populations has been a topic of discussion across regulators and the Share XA collaborative approach to greater diversity in clinical trialshttps://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/a-collaborative-approach-to-greater-diversity-in-clinical-trials/
Enabling new models of care: pursuing pharma’s partnership potentialThere is a huge, ongoing shift in how health and wellness is approached in the UK, and the Share XEnabling new models of care: pursuing pharma’s partnership potentialhttps://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/enabling-new-models-of-care-pursuing-pharmas-partnership-potential/
Nine for 2021: Addressing the pandemic legacyIn this second ‘Nine for 2021‘ article, IQVIA’s Sarah Rickwood looks at four issues which will directly impact Share XNine for 2021: Addressing the pandemic legacyhttps://pharmaphorum.com/views-analysis-sales-marketing/nine-for-2021-pandemic-legacy/
